Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 03, 2025 10:00 ET | Source: Baylor Genetics

Baylor Genetics Applauds Medi-Cal's Decision to Cover Whole Genome Sequencing

HOUSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading clinical diagnostic laboratory at the forefront of genetic testing, today announced its support for Medi-Cal's (California’s...
September 04, 2025 07:01 ET | Source: Bragar Eagel & Squire

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm

GeneDx shares fell 7% after Grizzly Research alleged fraudulent revenue schemes, code stacking, and insider stock sales signaling awareness of major risks.
September 01, 2025 11:08 ET | Source: The Rosen Law Firm PA

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Sept. 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx...
August 29, 2025 14:06 ET | Source: The Rosen Law Firm PA

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx...
August 14, 2025 14:30 ET | Source: The Rosen Law Firm PA

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx...
August 12, 2025 19:14 ET | Source: Bragar Eagel & Squire

GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
August 10, 2025 12:29 ET | Source: The Rosen Law Firm PA

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx...
August 06, 2025 19:01 ET | Source: Bragar Eagel & Squire

GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
July 29, 2025 19:25 ET | Source: Bragar Eagel & Squire

GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Lockheed Martin (LMT) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
July 29, 2025 15:39 ET | Source: The Rosen Law Firm PA

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx...